Katze M G, Detjen B M, Safer B, Krug R M
Mol Cell Biol. 1986 May;6(5):1741-50. doi: 10.1128/mcb.6.5.1741-1750.1986.
Selective translation of influenza viral mRNAs occurs after influenza virus superinfection of cells infected with the VAI RNA-negative adenovirus mutant dl331 (M. G. Katze, Y.-T. Chen, and R. M. Krug, Cell 37:483-490, 1984). Cell extracts from these doubly infected cells catalyze the initiation of essentially only influenza viral protein synthesis, reproducing the in vivo situation. This selective translation is correlated with a 5- to 10-fold suppression of the dl331-induced kinase that phosphorylates the alpha subunit of eucaryotic initiation factor eIF-2. This strongly suggests that influenza virus encodes a gene product that, analogous to the adenoviral VAI RNA, prevents the shutdown of overall protein synthesis caused by an eIF-2 alpha kinase turned on by viral infection. Adenoviral mRNA translation was restored to the extract from the doubly infected cells by the addition of the guanine nucleotide exchange factor eIF-2B, which is responsible for the normal recycling of eIF-2 during protein synthesis. This indicates that the residual kinase in the doubly infected cells leads to a limitation in functional (nonsequestered) eIF-2B and hence functional (GTP-containing) eIF-2 and that under these conditions influenza viral mRNAs are selectively translated over adenoviral mRNAs. Addition of double-stranded RNA to the extracts from these cells restored the eIF-2 alpha kinase to a level approaching that seen in extracts from cells infected with dl331 alone and caused the inhibition of influenza viral mRNA translation. This suggests that the putative influenza viral gene product acts against the double-stranded RNA activation of the kinase and indicates that influenza viral mRNA translation is also linked to the level of functional eIF-2. Our results thus indicate that a limitation in functional eIF-2 which causes a nonspecific reduction in the rate of initiation of protein synthesis results in the preferential translation of the better mRNAs (influenza viral mRNAs) at the expense of the poorer mRNAs (adenoviral mRNAs).
流感病毒mRNA的选择性翻译发生在感染了VAI RNA阴性腺病毒突变体dl331的细胞被流感病毒再次感染之后(M. G. 卡茨、Y.-T. 陈和R. M. 克鲁格,《细胞》37:483 - 490, 1984)。来自这些双重感染细胞的细胞提取物基本上只催化流感病毒蛋白合成的起始,重现了体内的情况。这种选择性翻译与dl331诱导的使真核起始因子eIF-2的α亚基磷酸化的激酶受到5至10倍的抑制相关。这强烈表明流感病毒编码一种基因产物,类似于腺病毒的VAI RNA,可防止由病毒感染激活的eIF-2α激酶导致的整体蛋白合成的关闭。通过添加鸟嘌呤核苷酸交换因子eIF-2B,腺病毒mRNA的翻译恢复到双重感染细胞提取物中的水平,eIF-2B负责蛋白合成过程中eIF-2的正常循环利用。这表明双重感染细胞中残留的激酶导致功能性(未被隔离)的eIF-2B受限,进而导致功能性(含GTP)的eIF-2受限,并且在这些条件下,流感病毒mRNA比腺病毒mRNA被选择性地翻译。向这些细胞的提取物中添加双链RNA使eIF-2α激酶恢复到接近仅感染dl331的细胞提取物中所见的水平,并导致流感病毒mRNA翻译受到抑制。这表明推测的流感病毒基因产物可对抗激酶的双链RNA激活,并表明流感病毒mRNA的翻译也与功能性eIF-2的水平相关。因此,我们的结果表明,功能性eIF-2的受限导致蛋白合成起始速率的非特异性降低,从而导致较好的mRNA(流感病毒mRNA)优先翻译,而较差的mRNA(腺病毒mRNA)则被牺牲。